Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £5.64m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Updated Key Information Document

20 Aug 2021 07:00

RNS Number : 1996J
Seed Innovations Limited
20 August 2021
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

20th August 2021

SEED Innovations Ltd ("SEED" or the "Company")

Updated Key Information Document

 

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that the Company has prepared an updated Key Information Document ("KID") which can now be viewed on SEED's website via the following link: https://seedinnovations.co/investor-centre/corporate-documents

***ENDS***

For further information on the Company please visit www.seedinnovations.co or contact:

Ed McDermott /

Lance de Jersey

SEED Innovations Ltd

Email:   info@seedinnovations.co

 

James Biddle /

Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

Isabella Pierre /

Damon Heath

Shard Capital Partners LLP

 

T: +44 (0)20 7186 9927

Catherine Leftley /

Isabel de Salis

St Brides Partners Ltd,

Financial PR

 

Email: info@stbridespartners.co.uk

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKCBQKBKDAFD
Date   Source Headline
27th Apr 202312:35 pmRNSInvestee Company Update: Little Green Pharma Ltd
24th Apr 20237:00 amRNSPortfolio Update: Northern Leaf CLN conversion
20th Apr 202310:01 amRNSSale of South West Brands to OTO for £6.2 million
17th Apr 202311:19 amRNSInvestee Company Update: Little Green Pharma LTD
11th Apr 20237:00 amRNSLeap Gaming Update – Offer Declared Unconditional
24th Mar 202311:04 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:26 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:25 amRNSInvestee Company Update: Little Green Pharma Ltd
15th Mar 202312:45 pmRNSAvextra AG Successfully Raises EUR 17 million
21st Feb 20237:00 amRNSPortfolio Company Update: South West Brands
15th Feb 202310:45 amRNSInvestee Company Update: Little Green Pharma Ltd
13th Feb 20233:00 pmRNSInvestee Company Update: Yooma Wellness Inc.
9th Feb 20237:15 amRNSInvestee Company Update: Avextra
6th Feb 20232:45 pmRNSInvestee Company Update: Little Green Pharma Ltd
16th Jan 20232:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Jan 20232:15 pmRNSDirector Share Purchase
15th Dec 20224:22 pmRNSDirector Share Purchase
14th Dec 20224:07 pmRNSDirector Share Purchases
12th Dec 20225:22 pmRNSInterim Results
7th Dec 20227:00 amRNSEUR14 million Offer for Leap Gaming
5th Dec 20227:00 amRNSInvestee Company Update: Clean Food Group Ltd
2nd Dec 202210:00 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Dec 20227:00 amRNSInvestee Company Update: Little Green Pharma Ltd
11th Nov 202210:15 amRNSPortfolio Company Update: South West Brands
2nd Nov 20221:20 pmRNSInvestee Company Update: Little Green Pharma
4th Oct 202212:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Oct 20227:30 amRNSInvestee Company Update: Avextra
16th Sep 20229:03 amRNSEurox – Change of Name to Avextra
7th Sep 20224:00 pmRNSResult of AGM & Updated Investor Presentation
2nd Sep 20222:50 pmRNSPortfolio Valuation Update & Investor Presentation
9th Aug 20227:00 amRNSNotice of AGM & Investor Presentation
8th Aug 20227:00 amRNSFurther Investment in South West Brands Limited
1st Aug 20227:00 amRNSNew Investment: Clean Food Group Ltd
21st Jul 20227:00 amRNSFinal Results
12th Jul 202212:10 pmRNSInvestee Company Update: Little Green Pharma Ltd
1st Jul 20225:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Jun 20223:05 pmRNSLoan to Portfolio Company, Leap Gaming
25th May 20222:08 pmRNSInvestee Company Update: Yooma Wellness Inc.
24th May 20227:00 amRNSInvestee Company Update: Leap Gaming
19th May 20227:00 amRNSInvestee Company Update - Little Green Pharma
18th May 20224:20 pmRNSInvestee Company Update: Yooma Wellness Inc.
4th May 20224:01 pmRNSInvestee Company Update: Yooma Wellness Inc.
3rd May 20227:00 amRNSInvestee Company Update - Little Green Pharma
19th Apr 20221:00 pmRNSInvestee Company Update: Little Green Pharma
6th Apr 20227:00 amRNSInvestee Company Update: Eurox Group
5th Apr 20227:00 amRNSFood Standard Agency’s Public List of CBD Products
31st Mar 202211:16 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Mar 20227:00 amRNSInvestee Company Update: Little Green Pharma Ltd
18th Feb 20229:41 amRNSInvestee Company Update: Little Green Pharma Ltd
8th Feb 20221:51 pmRNSInvestee Company Update: Little Green Pharma Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.